1. Neuronal Signaling MAPK/ERK Pathway NF-κB Apoptosis Stem Cell/Wnt
  2. Tau Protein p38 MAPK NF-κB Apoptosis Bcl-2 Family ERK JNK
  3. Tau Protein Phosphorylation-IN-1

Tau Protein Phosphorylation-IN-1 是一种 tau 蛋白 (tau protein) 磷酸化抑制剂,能有效保护 PC12 细胞免受 Aβ25-35 诱导的细胞毒性 (EC50 = 1.93 μM),并能穿透血脑屏障。Tau Protein Phosphorylation-IN-1 在体外和体内均能逆转 tau 蛋白的过度磷酸化,显著抑制免疫相关细胞毒性因子的表达,阻断 MAPKNF-κB 信号通路,并显著降低 RAGE 及凋亡 (apoptosis) 因子 Bax/Bcl-2 的表达水平。在阿尔茨海默病小鼠模型中,Tau Protein Phosphorylation-IN-1 可减轻小鼠的神经损伤并改善其学习记忆能力。Tau Protein Phosphorylation-IN-1 适用于阿尔茨海默病的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Tau Protein Phosphorylation-IN-1

Tau Protein Phosphorylation-IN-1 Chemical Structure

CAS No. : 3075165-36-2

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 p38 MAPK 亚型特异性产品:

查看 NF-κB 亚型特异性产品:

查看 Bcl-2 Family 亚型特异性产品:

查看 ERK 亚型特异性产品:

查看 JNK 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Tau Protein Phosphorylation-IN-1 is a tau protein phosphorylation inhibitor that potently protects PC12 cells against Aβ25–35-induced cytotoxicity (EC50 = 1.93 μM), and can penetrate the blood-brain barrier (BBB).Tau Protein Phosphorylation-IN-1 reverses the hyperphosphorylation of tau, significantly inhibits the expression of certain immune-related cytotoxic factors, suppresses the MAPK and NF-κB signaling pathways, and significantly inhibits the expression of RAGE and the apoptosis factors Bax/Bcl-2, both in vitro and in vivo. Tau Protein Phosphorylation-IN-1 relieves nerve damage, and improves learning and memory in an Alzheimer’s disease (AD) mouse model. Tau Protein Phosphorylation-IN-1 can be used for AD research[1].

体外研究
(In Vitro)

Tau Protein Phosphorylation-IN-1 (compound B1) (24 小时) 在 30 μM 浓度下对 PC12 细胞无毒性,在 10 μM 浓度下能显著抵抗 Aβ25-35 诱导的细胞毒性[1]
Tau Protein Phosphorylation-IN-1 (2.5-10 μM,24 小时) 在 Aβ25-35 诱导的 PC12 细胞中通过多重机制表现出神经保护作用,包括显著降低 Thr181、 Thr205 和 Ser396 位点的 tau 磷酸化水平,抑制 MAPKs (p38、ERK、JNK) 和 NF-κB 的磷酸化,逆转 Aβ 诱导的 iNOSCOX-2 表达上调,调控凋亡相关蛋白 Bax/Bcl-2 的表达并抑制 RAGE [1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: PC12 cells
Concentration: 2.5, 5 and 10 μM
Incubation Time: 24 h
Result: Decreased phosphorylated tau levels at Thr181, Thr205, and Ser396 sites caused by Aβ25–35 compared to the model group.
Exhibited stronger inhibition of tau phosphorylation at the Thr181, Thr205, and Ser396 sites than Oleanolic acid (OA)(HY-N0156) or Donepezil (HY-14566) at 10 μM.
Reversed the Aβ25–35-induced upregulation of iNOS and COX-2 levels.
Significantly inhibited RAGE expression at 5 and 10 μM.
Decreased Bax and Bcl-2 expression compared to the control group.
Inhibited the phosphorylation of p38 MAPK, ERK and JNK, thereby blocking the MAPK signaling pathway.
Reduced the expression of p-NF-κB in Aβ25–35-induced PC12 cells.
体内研究
(In Vivo)

Tau Protein Phosphorylation-IN-1 (2.5、5 和 10 mg/kg,腹腔注射,每日一次,持续 28 天) 能够改善阿尔茨海默病小鼠模型中小鼠的认知缺陷,减轻 tau 蛋白过度磷酸化,并抑制神经炎症[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male ICR mice (20-22 g) intracerebroventricularly injected with Aβ₂₅–₃₅ solution (9 nmol/3 μL/mouse) [1]
Dosage: 2.5, 5 and 10 mg/kg
Administration: i.p., daily for 28 days
Result: Reduced the escape latencies on training days 2-5 compared with the Aβ group in the Morris water maze test.
Increased the number of crossings over the original platform location, in contrast to the significant reduction observed in the Aβ group.
Reversed the Aβ-induced histopathological damage, including irregular neuronal distribution and reduced cell numbers in the hippocampal CA1 and CA3 areas.
Significantly reduced the levels of tau phosphorylation at Thr205, and Ser396 sites, compared with the Aβ group.
Significantly decreased the level of tau phosphorylation at the Thr181 site in the hippocampus, especially in the DG, CA1, and CA3 pyramidal neurons.
Suppressed the Aβ25-35-induced upregulation of iNOS, COX-2, RAGE, and the Bax/Bcl-2 ratio.
Showed an inhibitory effect on p38 MAPK, ERK, and JNK phosphorylation in Aβ25-35-induced AD mice.
Inhibited the Aβ25-35-induced upregulation of NF-κB in a dose-dependent manner.
Caused no histopathological damage in the liver or kidneys at any tested dose (up to 10 mg/kg) over 21 days.
分子量

628.89

Formula

C39H56N4O3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Tau Protein Phosphorylation-IN-1
目录号:
HY-175841
需求量: